ArticleAmerican journal of respiratory and critical care medicine2005

Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.

Eric Nuermberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.